{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:06:11Z","timestamp":1790168771813,"version":"4.1.0"},"reference-count":133,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:p>Stomach cancer is one of the most common cancers worldwide, despite its declining overall incidence. Although there are differences in incidence, etiology and pathological factors, most studies do not separately analyze cardia and noncardia gastric cancer. Surgery is the only potentially curative treatment for advanced, resectable gastric cancer, but locoregional relapse rate is high with a consequently poor prognosis. To improve survival, several preoperative and postoperative treatment strategies have been investigated. Whereas perioperative chemotherapy and postoperative chemoradiation (CRT) are considered standard therapy in the Western world, in Asia postoperative monochemotherapy with S-1 is often used. Several other therapeutic options, although generally not accepted as standard treatment, are postoperative combination chemotherapy, hyperthermic intraperitoneal chemotherapy and preoperative radiotherapy and CRT. Postoperative combination chemotherapy does show a statistically significant but clinically equivocal survival advantage in several meta-analyses. Hyperthermic intraperitoneal chemotherapy is mainly performed in Asia and is associated with a higher postoperative complication rate. Based on the currently available data, the use of postoperative radiotherapy alone and the use of intraoperative radiotherapy should not be advised in the treatment of resectable gastric cancer. Western randomized trials on gastric cancer are often hampered by slow or incomplete accrual. Reduction of toxicity for preoperative and especially postoperative treatment is essential for the ongoing improvement of gastric cancer care.<\/jats:p>","DOI":"10.1177\/1756283x11410771","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T02:36:33Z","timestamp":1317177393000},"page":"49-69","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":59,"title":["Treatment of resectable gastric cancer"],"prefix":"10.1177","volume":"5","author":[{"given":"Johan L.","family":"Dikken","sequence":"first","affiliation":[{"name":"Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands and Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.H.","family":"van de Velde","sequence":"additional","affiliation":[{"name":"Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Coit","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Verheij","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Cats","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.12.009"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2006.0030"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.305"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.015"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO;2-L"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4706"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4840"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.033"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2007.09.040"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf040"},{"key":"e_1_3_2_12_1","first-page":"868","article-title":"Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer","volume":"16","author":"Biffi R.","year":"2010","unstructured":"Biffi R., Fazio N., Luca F., Chiappa A., Andreoni B., Zampino M.G., et al. (2010) Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 16: 868\u2013874.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-11-199806010-00004"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.4510"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903253401202"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800830526"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi270"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(18)30035-8"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06578-3"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2007.06.009"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199908000-00006"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.19"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1564"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk131"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20731"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.128"},{"key":"e_1_3_2_27_1","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process\u2014First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa P.","year":"1992","unstructured":"Correa P. (1992) Human gastric carcinogenesis: a multistep and multifactorial process\u2014First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735\u20136740.","journal-title":"Cancer Res"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90498-5"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90144-0"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690243"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000143245.28656.15"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm128"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800750206"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<385::AID-CNCR2820440203>3.0.CO;2-8"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.137364"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9654"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(99)00076-3"},{"key":"e_1_3_2_40_1","volume-title":"AJCC Cancer Staging Manual","author":"Edge S.B.","year":"2010","unstructured":"Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. (2010) AJCC Cancer Staging Manual, 7th edn, Springer: New York.","edition":"7"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i19.2991"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.08.005"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.074237"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.20228"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820501)49:9<1771::AID-CNCR2820490907>3.0.CO;2-M"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901201)66:11<2324::AID-CNCR2820661112>3.0.CO;2-C"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198902000-00005"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/srao.2002.30817"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(82)90377-7"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114876"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92464-3"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyn017"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114504"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.026"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.04.013"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-004-8207-4"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.3.347"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.8.1441"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78818-0_6"},{"key":"e_1_3_2_62_1","unstructured":"Horner M.J. Ries L.A.G. Krapcho M. Neyman N. Aminou R. Howlader N. et al. (2009) SEER Cancer Statistics Review 1975\u20132006. Bethesda MD: National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/csr\/1975_2006\/."},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036288"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v8.i6.1023"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01163.x"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000151892.35922.f2"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603965"},{"key":"e_1_3_2_69_1","article-title":"Postoperative chemoradiotherapy in gastric cancer\u2013a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy","author":"Jansen E.P.","year":"2009","unstructured":"Jansen E.P., Boot H., Dubbelman R., Verheij M., Cats A. (2009) Postoperative chemoradiotherapy in gastric cancer\u2013a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol, in press.","journal-title":"Ann Oncol"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.05.004"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.09.012"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/11024150201680005"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00011681"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.2308"},{"key":"e_1_3_2_75_1","volume-title":"ASCO Annual Meeting 2008","author":"Kang Y.","year":"2008","unstructured":"Kang Y., Chang H. (2008) Postoperative adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer: A randomized phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short-term doxifluridine (Mf) (AMC 0101) (NCT00296322). In: ASCO Annual Meeting 2008."},{"key":"e_1_3_2_76_1","volume-title":"ASCO Annual Meeting","author":"Kang Y.","year":"2008","unstructured":"Kang Y., Chang H., Min Y., Zang D., Kim G., Yang D., et al. (2008) A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201). In: ASCO Annual Meeting."},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200009000-00008"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00534-6"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181cc8f6b"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.005"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(99)80004-3"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2002.120115"},{"key":"e_1_3_2_83_1","first-page":"283","article-title":"Surgical treatment of early gastric cancer","volume":"14","author":"Kitaoka H.","year":"1984","unstructured":"Kitaoka H., Yoshikawa K., Hirota T., Itabashi M. (1984) Surgical treatment of early gastric cancer. Jpn J Clin Oncol 14: 283\u2013293.","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.3.373"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi252"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/34.11.2478"},{"key":"e_1_3_2_87_1","first-page":"211","article-title":"[Adjuvant intraoperative radiotherapy of stomach carcinoma]","volume":"113","author":"Kramling H.J.","year":"1996","unstructured":"Kramling H.J., Wilkowski R., Duhmke E., Cramer C., Willich N., Schildberg F.W. (1996) [Adjuvant intraoperative radiotherapy of stomach carcinoma]. Langenbecks Arch Chir Suppl Kongressbd 113: 211\u2013213.","journal-title":"Langenbecks Arch Chir Suppl Kongressbd"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-008-9132-y"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/apm.1965.64.1.31"},{"key":"e_1_3_2_91_1","volume-title":"Proceedings of the ASCO Gastrointestinal Cancers Symposium","author":"Lee J.","year":"2009","unstructured":"Lee J., Kang W., Lim D. (2009) Phase III trial of adjuvant capecitabine\/cisplatin (XP) compared with capecitabine\/cisplatin\/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis. In: Proceedings of the ASCO Gastrointestinal Cancers Symposium."},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-004-8808-y"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.15_suppl.4515"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010187"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-004-0268-5"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9574-6"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008377101672"},{"key":"e_1_3_2_98_1","first-page":"360","article-title":"Surgical treatment for gastric cancer: the Japanese approach","volume":"23","author":"Maruyama K.","year":"1996","unstructured":"Maruyama K., Sasako M., Kinoshita T., Sano T., Katai H. (1996) Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 23: 360\u2013368.","journal-title":"Semin Oncol"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.11.1249"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s101200200000"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj077"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0038"},{"key":"e_1_3_2_103_1","first-page":"21","article-title":"Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses","volume":"88","author":"Panzini I.","year":"2002","unstructured":"Panzini I., Gianni L., Fattori P.P., Tassinari D., Imola M., Fabbri P., et al. (2002) Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88: 21\u201327.","journal-title":"Tumori"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji024"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2005.11.001"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.02.013"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072252"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.184"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.018"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707035"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.15_suppl.4510"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-7404(94)90022-1"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2007.04.012"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-006-0380-9"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200009000-00007"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80423-4"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10102"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2000.1002"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00591-9"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70070-X"},{"key":"e_1_3_2_121_1","first-page":"669","article-title":"Trends in incidence of oesophageal and stomach cancer subtypes in Europe","volume":"22","author":"Steevens J.","year":"2010","unstructured":"Steevens J., Botterweck A.A., Dirx M.J., van den Brandt P.A., Schouten L.J. (2010a) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 22: 669\u2013678.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.191080"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181d3d29b"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6408"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609034615"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-007-0420-0"},{"key":"e_1_3_2_127_1","volume-title":"TNM Classification of Malignant Tumors","author":"UICC","year":"2009","unstructured":"UICC. (2009) TNM Classification of Malignant Tumors, 7th edn, Wiley-Blackwell: New York.","edition":"7"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.06.014"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.12.942"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70623-4"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0250"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0975"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9487-4"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)00280-6"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756283X11410771","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1756283X11410771","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756283X11410771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:35:34Z","timestamp":1790166934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756283X11410771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1177\/1756283X11410771"],"URL":"https:\/\/doi.org\/10.1177\/1756283x11410771","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,27]]}}}